Cargando…
Low-dose hydroxychloroquine therapy and lower mortality in hospitalized patients with COVID-19: association does not mean causality
Autores principales: | De Schryver, Nicolas, Serck, Nicolas, Vinetti, Marco, Gérard, Ludovic |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier Ltd and International Society of Antimicrobial Chemotherapy.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7698675/ https://www.ncbi.nlm.nih.gov/pubmed/33259917 http://dx.doi.org/10.1016/j.ijantimicag.2020.106254 |
Ejemplares similares
-
Reply to ‘Low‐dose hydroxychloroquine therapy and lower mortality in hospitalized patients with COVID‐19: association does not mean causality’
por: Dauby, N., et al.
Publicado: (2021) -
The unfinished story of hydroxychloroquine in COVID-19: The right anti-inflammatory dose at the right moment?
por: Dauby, Nicolas, et al.
Publicado: (2021) -
The significance of correct dosing of hydroxychloroquine in clinical trials of COVID-19
por: Sadasivam, Balakrishnan, et al.
Publicado: (2020) -
Hydroxychloroquine at usual doses as an option for coronavirus disease 2019 treatment
por: Carbillon, Lionel, et al.
Publicado: (2021) -
Re: Effect of hydroxychloroquine with or without azithromycin on the mortality of COVID-19 patients: a systematic review and meta-analysis' by Fiolet et al.
por: Vedrines, Nicolas, et al.
Publicado: (2021)